Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Dietz, Steffen ^a,b   Schirmer, Uwe ^a,b   Mercé, Clémentine ^a,b   Von Bubnoff, Nikolas ^a,c   Dahl, Edgar ^d   Meister, Michael ^b,e   Muley, Thomas ^b,e   Thomas, Michael ^b,e   Sültmann, Holger ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b German Center for Lung Research (DZL)   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ALK GENE; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; DNA SEQUENCE; EXOME; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MTOR GENE; NON SMALL CELL LUNG CANCER; PIK3CA GENE; PRIMARY TUMOR; PTEN GENE; SEQUENCE ANALYSIS; SERUM; UNTRANSLATED REGION; BLOOD; CANCER STAGING; GENETICS; LUNG TUMOR; MUTATION; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; EXOME; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM STAGING; SEQUENCE ANALYSIS, DNA;

EID: 84984780854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161012     Document Type: Article

References (52)

1. Leary RJ, Sausen M, Kinde I, Papadopoulos N, Carpten JD, Craig D, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med. 2012; 4 (162):162ra54. doi: 10.1126/scitranslmed.3004742 PMID: 23197571; PubMed Central PMCID: PMCPMC3641759.
2. Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012; 4 (136):136ra68. doi: 10.1126/scitranslmed.3003726 PMID: 22649089.
3. De Mattos-Arruda L, Weigelt B, Cortes J, Won HH, Ng CK, Nuciforo P, et al. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. Ann Oncol. 2014; 25(9):1729-35. doi: 10.1093/annonc/mdu239 PMID: 25009010.
4. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev. 1994; 3 (1):67-71. PMID: 8118388.
5. de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014; 346(6206):251-6. doi: 10.1126/science.1253462 PMID: 25301630; PubMed Central PMCID: PMCPMC4636050.
6. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-92. doi: 10.1056/NEJMoa1113205 PMID: 22397650.
7. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med. 2014; 6(224):224ra24. doi: 10.1126/scitranslmed.3007094 PMID: 24553385; PubMed Central PMCID: PMCPMC4017867.
8. Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014; 20(4):430-5. doi: 10.1038/nm.3511 PMID: 24658074.
9. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008; 14(9):985-90. doi: 10.1038/nm.1789 PMID: 18670422; PubMed Central PMCID: PMCPMC2820391.
10. Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013; 368(13):1199-209. doi: 10.1056/NEJMoa1213261 PMID: 23484797.
11. Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013; 497(7447):108-12. doi: 10.1038/nature12065 PMID: 23563269.
12. Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014; 20(5):548-54. doi: 10.1038/nm.3519 PMID: 24705333; PubMed Central PMCID: PMCPMC4016134.
13. Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014; 32 (6):579-86. doi: 10.1200/JCO.2012.45.2011 PMID: 24449238.
14. McBride DJ, Orpana AK, Sotiriou C, Joensuu H, Stephens PJ, Mudie LJ, et al. Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer. 2010; 49(11):1062-9. doi: 10.1002/gcc.20815 PMID: 20725990; PubMed Central PMCID: PMCPMC3145117.
15. Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005; 102(45):16368-73. doi: 10.1073/pnas.0507904102 PMID: 16258065; PubMed Central PMCID: PMCPMC1283450.
16. Wang Z, Chen R, Wang S, Zhong J, Wu M, Zhao J, et al. Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC. PLoS One. 2014; 9(11):e110780. doi: 10.1371/journal.pone.0110780 PMID: 25405807; PubMed Central PMCID: PMCPMC4236040.
17. Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, Wong VW, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A. 2015; 112(11):E1317-25. doi: 10.1073/pnas.1500076112 PMID: 25646427; PubMed Central PMCID: PMCPMC4372002.
18. Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012; 489(7417):519-25. doi: 10.1038/nature11404 PMID: 22960745; PubMed Central PMCID: PMCPMC3466113.
19. Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014; 511(7511):543-50. doi: 10.1038/nature13385 PMID: 25079552; PubMed Central PMCID: PMCPMC4231481.
20. Alexandrov LB, Stratton MR. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev. 2014; 24:52-60. doi: 10.1016/j.gde.2013.11.014 PMID: 24657537; PubMed Central PMCID: PMCPMC3990474.
21. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484):495-501. doi: 10.1038/nature12912 PMID: 24390350; PubMed Central PMCID: PMCPMC4048962.
22. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013; 339(6127):1546-58. doi: 10.1126/science.1235122 PMID: 23539594; PubMed Central PMCID: PMCPMC3749880.
23. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5): E359-86. doi: 10.1002/ijc.29210 PMID: 25220842.
24. Mohan S, Heitzer E, Ulz P, Lafer I, Lax S, Auer M, et al. Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. PLoS Genet. 2014; 10 (3):e1004271. doi: 10.1371/journal.pgen.1004271 PMID: 24676216; PubMed Central PMCID: PMCPMC3967949.
25. Butler TM, Johnson-Camacho K, Peto M, Wang NJ, Macey TA, Korkola JE, et al. Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease. PLoS One. 2015; 10(8):e0136407. doi: 10.1371/journal.pone.0136407 PMID: 26317216; PubMed Central PMCID: PMCPMC4552879.
26. Klevebring D, Neiman M, Sundling S, Eriksson L, Darai Ramqvist E, Celebioglu F, et al. Evaluation of exome sequencing to estimate tumor burden in plasma. PLoS One. 2014; 9(8):e104417. doi: 10.1371/journal.pone.0104417 PMID: 25133800; PubMed Central PMCID: PMCPMC4136786.
27. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. doi: 10.1093/bioinformatics/btp324 PMID: 19451168; PubMed Central PMCID: PMCPMC2705234.
28. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. doi: 10.1093/bioinformatics/btp352 PMID: 19505943; PubMed Central PMCID: PMCPMC2723002.
29. Hummel M, Bonnin S, Lowy E, Roma G. TEQC: an R package for quality control in target capture experiments. Bioinformatics. 2011; 27(9):1316-7. doi: 10.1093/bioinformatics/btr122 PMID: 21398674.
30. Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. doi: 10.1038/nature15393 PMID: 26432245; PubMed Central PMCID: PMCPMC4750478.
31. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. doi: 10.1101/gr.107524.110 PMID: 20644199; PubMed Central PMCID: PMCPMC2928508.
32. Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012; 6(2):80-92. doi: 10.4161/fly.19695 PMID: 22728672; PubMed Central PMCID: PMCPMC3679285.
33. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, et al. The variant call format and VCFtools. Bioinformatics. 2011; 27(15):2156-8. doi: 10.1093/bioinformatics/btr330 PMID: 21653522; PubMed Central PMCID: PMCPMC3137218.
34. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011; 29(1):24-6. doi: 10.1038/nbt.1754 PMID: 21221095; PubMed Central PMCID: PMCPMC3346182.
35. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008; 105(42):16266-71. doi: 10.1073/pnas.0808319105 PMID: 18838674; PubMed Central PMCID: PMCPMC2562413.
36. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010; 2(61):61ra91. doi: 10.1126/scitranslmed.3001720 PMID: 21148127.
37. Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell. 2016; 164(1-2):57-68. doi: 10.1016/j.cell.2015. 11.050 PMID: 26771485; PubMed Central PMCID: PMCPMC4715266.
38. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001; 61(4):1659-65. PMID: 11245480.
39. Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M, et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 2010; 38(18):6159-75. doi: 10.1093/nar/gkq421 PMID: 20494973; PubMed Central PMCID: PMCPMC2952865.
40. Heitzer E, Auer M, Hoffmann EM, Pichler M, Gasch C, Ulz P, et al. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int J Cancer. 2013; 133(2):346-56. doi: 10.1002/ijc.28030 PMID: 23319339; PubMed Central PMCID: PMCPMC3708119.
41. Rykalina VN, Shadrin AA, Amstislavskiy VS, Rogaev EI, Lehrach H, Borodina TA. Exome sequencing from nanogram amounts of starting DNA: comparing three approaches. PLoS One. 2014; 9(7): e101154. doi: 10.1371/journal.pone.0101154 PMID: 24992588; PubMed Central PMCID: PMCPMC4081514.
42. Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C, et al. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011; 12(2):R18. doi: 10.1186/gb-2011-12-2-r18 PMID: 21338519; PubMed Central PMCID: PMCPMC3188800.
43. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, Turner DJ. Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G+C)-biased genomes. Nat Methods. 2009; 6(4):291-5. doi: 10.1038/nmeth.1311 PMID: 19287394; PubMed Central PMCID: PMCPMC2664327.
44. Kane MD, Jatkoe TA, Stumpf CR, Lu J, Thomas JD, Madore SJ. Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res. 2000; 28(22):4552-7. PMID: 11071945; PubMed Central PMCID: PMCPMC113865.
45. Belkadi A, Bolze A, Itan Y, Cobat A, Vincent QB, Antipenko A, et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc Natl Acad Sci U S A. 2015; 112(17):5473-8. doi: 10.1073/pnas.1418631112 PMID: 25827230; PubMed Central PMCID: PMCPMC4418901.
46. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009; 461(7261):272-6. doi: 10.1038/nature08250 PMID: 19684571; PubMed Central PMCID: PMCPMC2844771.
47. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012; 337 (6090):64-9. doi: 10.1126/science.1219240 PMID: 22604720; PubMed Central PMCID: PMCPMC3708544.
48. Frenel JS, Carreira S, Goodall J, Roda D, Perez-Lopez R, Tunariu N, et al. Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration. Clin Cancer Res. 2015; 21(20):4586-96. doi: 10.1158/1078-0432.CCR-15-0584 PMID: 26085511; PubMed Central PMCID: PMCPMC4580992.
49. Frumkin D, Wasserstrom A, Kaplan S, Feige U, Shapiro E. Genomic variability within an organism exposes its cell lineage tree. PLoS Comput Biol. 2005; 1(5):e50. doi: 10.1371/journal.pcbi.0010050 PMID: 16261192; PubMed Central PMCID: PMCPMC1274291.
50. Gomez-Ramos A, Sanchez-Sanchez R, Muhaisen A, Rabano A, Soriano E, Avila J. Similarities and differences between exome sequences found in a variety of tissues from the same individual. PLoS One. 2014; 9(7):e101412. doi: 10.1371/journal.pone.0101412 PMID: 24984015; PubMed Central PMCID: PMCPMC4077829.
51. Holstege H, Pfeiffer W, Sie D, Hulsman M, Nicholas TJ, Lee CC, et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res. 2014; 24(5):733-42. doi: 10.1101/gr.162131.113 PMID: 24760347; PubMed Central PMCID: PMCPMC4009603.
52. Lupski JR. Genetics. Genome mosaicism - one human, multiple genomes. Science. 2013; 341 (6144):358-9. doi: 10.1126/science.1239503 PMID: 23888031.